Back
Black Diamond Therapeutics Vs. Vanda Pharmaceuticals Industry Stock Comparison
Sell
31
BDTX
Black Diamond Therapeutics
Last Price:
2.57
Seasonality Move:
28.2%
Sell
43
VNDA
Vanda Pharmaceuticals
Last Price:
5.20
Seasonality Move:
4.28%
Sell
31
Black Diamond Therapeutics (BDTX)
is a Sell
Is Black Diamond Therapeutics a Buy, Sell or Hold?
- The current Black Diamond Therapeutics [BDTX] share price is $2.57. The Score for BDTX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- BDTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Vanda Pharmaceuticals (VNDA)
is a Sell
Is Vanda Pharmaceuticals a Buy, Sell or Hold?
- The current Vanda Pharmaceuticals [VNDA] share price is $5.19. The Score for VNDA is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- VNDA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BDTX Stock Price Chart
What is Black Diamond Therapeutics's stock price today?
-
The Black Diamond Therapeutics share price today is $2.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
VNDA Stock Price Chart
What is Vanda Pharmaceuticals's stock price today?
-
The Vanda Pharmaceuticals share price today is $5.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VNDA is experiencing slight selling pressure.
BDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 37.09 | Sell |
Chaikin Money Flow: | 347120 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.56 - 3.16) | Sell |
Bollinger Bands (100): | (3.22 - 5.86) | Sell |
VNDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 58.12 | Buy |
Chaikin Money Flow: | -101898 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.69 - 5.19) | Buy |
Bollinger Bands (100): | (4.66 - 5.62) | Buy |
BDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.5 | Buy |
20-day SMA: | 2.84 | Sell |
50-day SMA: | 3.37 | Sell |
200-day SMA: | 4.83 | Sell |
8-day EMA: | 2.58 | Sell |
20-day EMA: | 2.8 | Sell |
50-day EMA: | 3.4 | Sell |
200-day EMA: | 4.24 | Sell |
VNDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.01 | Buy |
20-day SMA: | 5.02 | Buy |
50-day SMA: | 4.81 | Buy |
200-day SMA: | 4.99 | Buy |
8-day EMA: | 5.06 | Buy |
20-day EMA: | 5 | Buy |
50-day EMA: | 4.96 | Buy |
200-day EMA: | 5.04 | Buy |
Black Diamond Therapeutics Earnings Growth & BDTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.02 per share.
Vanda Pharmaceuticals Earnings Growth & VNDA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Black Diamond Therapeutics Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Vanda Pharmaceuticals Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |